Advertisement

Topics

Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI

02:15 EST 11 Jan 2019 | pharmaphorum

Artificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of technology for drug discovery. The companies are the latest to use AI and machine learning to make the drug development process...

Original Article: Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI

NEXT ARTICLE

More From BioPortfolio on "Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...